Acura Pharmaceuticals Share Holder Equity 2010-2021 | ACUR

Acura Pharmaceuticals share holder equity from 2010 to 2021. Share holder equity can be defined as the sum of preferred and common equity items
Acura Pharmaceuticals Annual Share Holder Equity
(Millions of US $)
2021 $0
2020 $-6
2019 $-5
2018 $-4
2017 $0
2016 $1
2015 $8
2014 $5
2013 $18
2012 $28
2011 $37
2010 $24
2009 $30
Acura Pharmaceuticals Quarterly Share Holder Equity
(Millions of US $)
2021-12-31 $0
2021-09-30 $0
2021-06-30 $0
2021-03-31 $-6
2020-12-31 $-6
2020-09-30 $-6
2020-06-30 $-5
2020-03-31 $-5
2019-12-31 $-5
2019-09-30 $-5
2019-06-30 $-5
2019-03-31 $-4
2018-12-31 $-4
2018-09-30 $-4
2018-06-30 $-3
2018-03-31 $-1
2017-12-31 $0
2017-09-30 $2
2017-06-30 $0
2017-03-31 $2
2016-12-31 $1
2016-09-30 $0
2016-06-30 $2
2016-03-31 $5
2015-12-31 $8
2015-09-30 $9
2015-06-30 $4
2015-03-31 $7
2014-12-31 $5
2014-09-30 $8
2014-06-30 $10
2014-03-31 $14
2013-12-31 $18
2013-09-30 $21
2013-06-30 $20
2013-03-31 $23
2012-12-31 $28
2012-09-30 $30
2012-06-30 $32
2012-03-31 $34
2011-12-31 $37
2011-09-30 $38
2011-06-30 $40
2011-03-31 $22
2010-12-31 $24
2010-09-30 $26
2010-06-30 $27
2010-03-31 $28
2009-12-31 $30
2009-09-30 $32
2009-06-30 $33
2009-03-31 $37
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $0.001B $0.000B
Halsey Drug Company, Inc. is engaged in the manufacture, sale and distribution of generic drugs. A generic drug is the chemical and therapeutic equivalent of a brand-name drug for which patent protection has expired. The company sells its generic drug products under its Halsey label and under private-label arrangements with drugstore chains and drug wholesalers.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $15.477B 5.66
Dr Reddy's Laboratories (RDY) India $11.411B 21.77
BridgeBio Pharma (BBIO) United States $6.430B 0.00
Bausch Health Cos (BHC) Canada $1.876B 1.36
Supernus Pharmaceuticals (SUPN) United States $1.717B 16.02
Amphastar Pharmaceuticals (AMPH) United States $1.109B 6.71
Personalis (PSNL) United States $0.282B 0.00
Taysha Gene Therapies (TSHA) United States $0.254B 0.00
Assembly Biosciences (ASMB) United States $0.075B 0.00
Sol-Gel Technologies (SLGL) Israel $0.015B 0.00
Evoke Pharma (EVOK) United States $0.003B 0.00
Teligent (TLGT) United States $0.000B 0.00